Biocon Biologics and Voluntis introduce Insulia, an FDA-cleared, Digital Therapeutic in India This collaboration will help patients around the globe achieve optimal outcomes on their insulin journey and illustrates digital…
Biocon Biologics organises ‘100 years of Insulin – Delivering on Universal Access & Equitable… The symposium was opened by Satish Sivan, Deputy Chief of Mission, Embassy of India in Korea, who appreciated efforts made by…
